• 5-EdU Workflows for S Phase DNA Synthesis

  2026-08-24

  Turn a short 5-EdU pulse into a sensitive readout of newly synthesized DNA for stem-cell, tumor, and regeneration models. This workflow emphasizes assay design, quantitative controls, and troubleshooting so click-based detection remains biologically interpretable.

• Tetracycline as a Translational Research Bridge

  2026-08-23

  Tetracycline is more than a broad-spectrum polyketide antibiotic: it is a disciplined workflow tool for selection, ribosomal function research, and model quality control. This article connects its established antibacterial mechanism with the QRICH1–ER stress–HMGB1 axis reported in HBV-associated hepatic fibrosis, while clearly separating evidence from strategic extrapolation.

• Isoprenaline Hydrochloride in Heart–Brain Assays

  2026-08-22

  Isoprenaline Hydrochloride is more than a cardiac stimulant: it can encode sympathetic cardiac stress for mechanistic heart–brain experiments. This guide explains how isoproterenol exposure, causal controls, and multimodal readouts can distinguish cardiac drivers from downstream neural and behavioral effects.

• GPNMB Model Predicts ESCC Immunotherapy Response

  2026-08-22

  The reference study identifies circulating soluble GPNMB as a mechanistic biomarker of CD8+ T-cell exhaustion and resistance to PD-1 blockade in esophageal squamous cell carcinoma. Its multimodal model combines plasma GPNMB, CAF-Epi niche features, and clinicopathological variables to improve response and survival prediction across retrospective and prospective cohorts.

• ASB3-MAVS Ubiquitination in Antiviral Immunity

  2026-08-21

  The 2024 reference study identifies ASB3 as an inducible negative regulator of antiviral innate immunity that targets MAVS for K48-linked ubiquitination and proteasomal degradation. Its genetic, infection, biochemical, and animal experiments connect ASB3 activity to reduced TBK1–IRF3 signaling, impaired type I interferon production, and increased susceptibility to influenza A virus.

• BOP Reagent and Translational Prodrug Design

  2026-08-20

  BOP reagent is more than a peptide coupling reagent: its controlled carboxyl activation can support modular synthesis strategies that matter for translational prodrug research. This article connects peptide-bond chemistry with the carrier-free, ROS-responsive triterpene platform reported for oral squamous cell carcinoma, while separating established chemistry from preclinical opportunity.

• EdU Imaging Kits (488) for Stem Cell Proliferation

  2026-08-20

  EdU Imaging Kits (488) translate DNA replication into a clear fluorescence signal without the harsh denaturation required by BrdU assays. The workflow is especially useful for comparing disease-associated stem-cell proliferation, preserving morphology and antigen-binding sites, and combining microscopy with flow cytometry.

• Neuritin, ER Stress, and Early Brain Injury After SAH

  2026-08-19

  This Brain Research study identifies coordinated endoplasmic reticulum stress–inflammatory signaling as a mechanistic link between subarachnoid hemorrhage, neuroinflammation, and neuronal apoptosis. Its central finding is that neuritin overexpression suppresses three NF-κB-associated ER stress pathways, providing a framework for separating upstream stress signaling from downstream tissue injury.

• PNU 74654: Wnt Pathway Inhibitor Guide

  2026-08-19

  PNU 74654 is a small-molecule Wnt signaling pathway inhibitor for controlled studies of Wnt/β-catenin signaling inhibition. Its product specifications support use in cancer research, stem cell research, and cell proliferation modulation, while the cited muscle study provides biological context rather than direct evidence for PNU 74654 activity.

• Elbasvir/Grazoprevir: Evidence for HCV Treatment

  2026-08-18

  The reference review explains why combining the NS5A inhibitor elbasvir with the NS3/4A protease inhibitor grazoprevir provides complementary suppression of hepatitis C virus replication. Its synthesis of pharmacology, genotype-specific potency, clinical efficacy, safety, resistance, and special-population data supports the combination’s role in HCV genotype 1 and 4 treatment, while also defining important limits involving liver status and drug interactions.

• Colistin–Gamithromycin Synergy in Murine Pneumonia

  2026-08-18

  The reference study shows that colistin and gamithromycin can act synergistically against selected Pasteurella multocida isolates in vitro and in a neutropenic murine lung infection model. Its PK/PD analysis further identifies exposure-based dosing relationships, while the isolate-dependent response highlights why combination therapy should be guided by susceptibility and pharmacological data.

• SB-505124 Hydrochloride in Mechanobiology

  2026-08-17

  SB-505124 hydrochloride is a reversible ALK4/5/7 inhibitor for separating TGF-β signaling from cancer-cell mechanics. This guide translates the MRTFA–KCNMB1 findings into rigorous assay design, with practical controls for fibrosis, mechanobiology, and metastasis research.

• Elbasvir and Grazoprevir for Hepatitis C: Evidence Review

  2026-08-17

  This evidence-focused review examines how complementary NS5A and NS3/4A inhibition supports effective treatment of HCV genotype 1 and 4 infections. It also explains the pharmacologic, clinical, resistance, safety, and special-population findings synthesized by Wang, Huang, and Yu, with practical guidance for translating the evidence into research workflows.

• Simvastatin (Zocor): Lipid and Cancer Workflows

  2026-08-16

  Build reproducible HepG2 lipid-disorder, cholesterol, and hepatic cancer assays with Simvastatin (Zocor) as a mechanistically defined benchmark. This guide connects practical dosing, lipidomics, apoptosis, and troubleshooting strategies while distinguishing literature-backed conditions from optimization starting points.

• PP 3: A Better Control for Src Assays

  2026-08-15

  PP 3, or 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, is a research use only chemical for separating Src-dependent effects from downstream calcium-channel mechanisms. This guide translates vascular ROS findings into a practical control strategy for rigorous kinase assays.

8443 records 1/563 page Next 12345 下5页 Last page